The Technical Analyst
Select Language :
Karuna Therapeutics Inc [KRTX]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Karuna Therapeutics Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

Karuna Therapeutics Inc is listed at the  Exchange

0.03% $329.83

America/New_York / 15 mar 2024 @ 16:00


Karuna Therapeutics Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 12 599 mill
EPS: -11.74
P/E: -28.09
Earnings Date: May 02, 2024
SharesOutstanding: 38.20 mill
Avg Daily Volume: 0.972 mill
RATING 2024-03-15
B
Neutral
RATINGS
Rating CashFlow: Neutral
Return On Equity: Sell
Return On Asset: Neutral
DE: Sell
P/E: Strong Sell
Price To Book: Strong Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenuen/an/a
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -28.09 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-4.78x
Company: PE -28.09 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$4.56
(-98.62%) $-325.27
Date: 2024-03-20
Expected Trading Range (DAY)

$ 325.80 - 333.86

( +/- 1.22%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-18 Wheadon David E. Sell 990 Common Stock
2024-03-18 Wheadon David E. Sell 25 000 Option (right to buy)
2024-03-18 Wheadon David E. Sell 8 500 Option (right to buy)
2024-03-18 Wheadon David E. Sell 5 000 Option (right to buy)
2024-03-18 Wheadon David E. Sell 1 904 Option (right to buy)
INSIDER POWER
-93.83
Last 100 transactions
Buy: 115 486 | Sell: 3 548 924

Forecast: 01:40 - $362.99

Live Trading Signals (every 1 min)

SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $329.83 (0.03% )
Volume 1.283 mill
Avg. Vol. 0.972 mill
% of Avg. Vol 132.02 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Karuna Therapeutics Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Karuna Therapeutics Inc

RSI

Intraday RSI14 chart for Karuna Therapeutics Inc

Last 10 Buy & Sell Signals For KRTX

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:34sell$316.15N/AActive
Profile picture for
            Karuna Therapeutics Inc

KRTX

Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients with schizophrenia; and for the treatment of central nervous system disorders, such as negative and cognitive symptoms of schizophrenia and psychosis, as well as for the treatment of dementia-related psychosis. The company also focuses on developing other muscarinic-targeted drug candidates. Karuna Therapeutics, Inc. has a license agreement with Eli Lilly and Company, and Zai Lab (Shanghai) Co., Ltd; patent license agreement with PureTech Health LLC; and drug discovery partnership with Charles River Laboratories, as well as drug discovery collaboration with PsychoGenics, Inc. The company was formerly known as Karuna Pharmaceuticals, Inc. and changed its name to Karuna Therapeutics, Inc. in March 2019. Karuna Therapeutics, Inc. was incorporated in 2009 and is headquartered in Boston, Massachusetts.

Last 10 Buy Signals

Date Signal @
OMUSDMar 29 - 05:190.710
KUBUSDMar 29 - 05:132.70
EOSUSDMar 29 - 05:15$1.083
HATUSDMar 29 - 05:023 532.25
FETUSDMar 29 - 04:58$3.24
SOCKSUSDMar 29 - 04:5335 606
OSHIUSDMar 29 - 04:4981.91
HBTCUSDMar 29 - 04:3834 558
DESOUSDMar 29 - 04:3931.41
ARUSDMar 29 - 04:28$41.19

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.